Monod Bio is a pioneer company in the design of de novo protein biosensors. Our innovative biosensor platform technology takes advantage of the most recent advances in computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and inexpensive analytical assays. Our visionary founding team and state-of-the-art technology position Monod Bio at the forefront of biosensor innovation, and we welcome exceptional individuals to join us in this journey.
| Website | https://www.monod.bio/ |
| Employees | 27 (23 on RocketReach) |
| Founded | 2021 |
| Address | 4000 Mason Rd, Seattle, Washington 98195, US |
| Phone | +1 206-822-1255 |
| Industry | Biotechnology Research |
| Keywords | Biosensors, Biosensing Technology, Protein Engineering, Biomolecular Engineering, Protein Design, Molecular Engineering, Biotechnology Tools, Biotechnology, Diagnostic Tools, Synthetic Biology, Biomedical Engineering, Drug Discovery |
| Competitors | Amgen, Ubisoft Montréal, Evonik, Novozymes, Codexis, Inc., LanzaTech, Geno, Zymergen, Inc., Synthace, CARBIOS +30 more (view full list) |
Looking for a particular Monod Bio employee's phone or email?
Daniel-Adriano S is the CEO and President of Monod Bio.
23 people are employed at Monod Bio.
Monod Bio is based in Seattle, Washington.